CMPS

COMPASS Pathways plc (CMPS)

Last Price$3.7(6.6%)

Market Cap$253.4M

Relative value

$2.6

Overvalued (Relative Value)

28.8%

NTM P/E

(1.8x)

Peer set median: 16.7x

1Y Fwd EV/EBITDA

N/A

Peer set median: 8.6x

Stock quality

5/10

Good

is 30.5% overvalued

undervalued stocks

Start beating the S&P 500

CMPS Relative Value & Intrinsic Value

Key Highlights:

Relative Value vs Current Share Price

As of Mar 03, 2025 CMPS Relative Value is $2.6, which is overvalued by 28.8%, compared to current share price of $3.7.

DCF Value vs Current Share Price

As of Mar 03, 2025 CMPS DCF Value is N/A, which is undervalued by N/A, compared to current share price of $3.7.

Methodology

Price per share, $

Intrinsic value$2.6

Overvalued by30.5%

Current share price

3.7

2.6

not available

Best stock ideas on the market right now

With Value Sense, you can find undervalued stocks list with intrinsic value. Discover more stock market investment ideas.

Undervalued stocks right now

Undervalued stocks right now

Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 32.1%

S&P Outperformance 19.1%

Next 3M Predicted Return 20.3%

Low P/E stocks

Low P/E stocks

Explore the best low P/E stocks to buy in 2025, featuring top companies trading at low P/E ratios.

S&P Outperformance -5.5%

Next 3M Predicted Return 10.2%

Undervalued dividend stocks

Undervalued dividend stocks

Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.

3M Return 28.4%

S&P Outperformance 15.4%

Next 3M Predicted Return 16.9%

CMPS Valuation Multiples comparison vs Peer Set

LTM

NTM

1Y Forward

2Y Forward

EV/Revenue

General

Valuation Multiple

Financial metrics

Company name

EV/Revenue

Revenue growth

EBITDA margin

Net Income margin

COMPASS Pathways plcCMPS

Median Peer Set

1.4x

7.6%

22.3%

7.2%

Acadia Healthcare Company, Inc.ACHC

Chemed CorporationCHE

Encompass Health CorporationEHC

The Ensign Group, Inc.ENSG

Fresenius Medical Care AG & Co. KGaAFMS

HCA Healthcare, Inc.HCA

Option Care Health, Inc.OPCH

Tenet Healthcare CorporationTHC

Universal Health Services, Inc.UHS

CMPS Valuation multiples overview

LTM

NTM

1Y Forward

2Y Forward

21.5x (as of Mar 03, 2025)

EV/Gross Profit

46.0x (as of Mar 03, 2025)

(0.5x) (as of Mar 03, 2025)

(0.5x) (as of Mar 03, 2025)

(0.8x) (as of Mar 03, 2025)

(0.8x) (as of Mar 03, 2025)

68.8x (as of Mar 03, 2025)

147.6x (as of Mar 03, 2025)

(1.5x) (as of Mar 03, 2025)

(1.7x) (as of Mar 03, 2025)

(2.4x) (as of Mar 03, 2025)

(2.4x) (as of Mar 03, 2025)

(1.8x) (as of Mar 03, 2025)

1.3x (as of Mar 03, 2025)

(0.9x) (as of Mar 03, 2025)

CMPS Valuation multiples history vs. Peer set

Crunching data... Almost there!

Explore more intrinsic value tools hub for CMPS

DCF value calculator

Peter Lynch Fair Value

Earnings Power Value

Intrinsic Value

Margin of safety

Peter Lynch charts

Earnings growth model

Ben Graham Fair Value

FAQ

What is COMPASS Pathways plc relative value?

As of Mar 03, 2025, Apple Relative Value is $2.6. This suggests it may be overvalued by 28.8% compared to its current price of around $3.7.

What is COMPASS Pathways plc DCF (discounted cash flow) valuation?

As of Mar 03, 2025, COMPASS Pathways plc's Discounted Cash Flow (DCF) valuation estimates its share price at N/A. This suggests it may be overvalued by N/A to its current price of around $3.7, using a discount rate of N/A and terminal growth rate of 3.0%.

What is COMPASS Pathways plc intrinsic value?

As of Mar 03, 2025, Apple Intrinsic Value is $2.6. This suggests it may be overvalued by 30.5% compared to its current price of around $3.7.